Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 20Thoracic 4Head & Neck 4Breast 4Genitourinary 3Sarcoma 2Gynecologic 2Dermatologic 2Other neoplasm 1CNS 1

Conditions

Precancerous Conditions 4Head and Neck Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Papillomavirus Infections 2Tongue Neoplasms 1Stomach Neoplasms 1Salivary Gland Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Gastritis, Hypertrophic 1

Interventions

Gastroscopes 1Endoscopic Mucosal Resection 1Cetuximab 1Argon Plasma Coagulation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Cetuximab × Other neoplasm × Clear all
NCT00477880 2017-01-10

Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer

Vanderbilt University Medical Center

Phase 1 Completed
9 enrolled
GastrointestinalOther neoplasm

Gastritis, Hypertrophic, Precancerous Conditions, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡